Fluoropharma Medical
FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. The company was founded in 2003 and is headquartered in Montclair, New Jersey.
Fluoropharma Medical (FPMI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2016: 0.011x
Based on the latest financial reports, Fluoropharma Medical (FPMI) has a cash flow conversion efficiency ratio of 0.011x as of December 2016.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-116.24K) by net assets ($-10.18 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Fluoropharma Medical - Cash Flow Conversion Efficiency Trend (2007–2016)
This chart illustrates how Fluoropharma Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Fluoropharma Medical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Fluoropharma Medical ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ruzy Madencilik ve Enerji Yatirimlari Sanayi ve Ticaret A.S.
IS:RUZYE
|
N/A |
|
VELOGIC HOLDING COMPANY LIMITED
SEM:VELG
|
N/A |
|
Ba Ria Thermal Power JSC
VN:BTP
|
-0.010x |
|
Sienna Biopharmaceuticals Inc
PINK:SNNAQ
|
-0.772x |
|
Global Blockchain Acquisition Corp. Warrant
NASDAQ:GBBKW
|
-0.095x |
|
MULTISTRADA ARAH SA (QGH.SG)
STU:QGH
|
N/A |
|
PRECISE BIOMETRICS (PBCB.SG)
STU:PBCB
|
0.022x |
|
Grempco
WAR:GRM
|
N/A |
Annual Cash Flow Conversion Efficiency for Fluoropharma Medical (2007–2016)
The table below shows the annual cash flow conversion efficiency of Fluoropharma Medical from 2007 to 2016.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2016-12-31 | $-10.18 Million | $-880.12K | 0.086x | -74.61% |
| 2015-12-31 | $-7.86 Million | $-2.68 Million | 0.341x | -50.82% |
| 2014-12-31 | $-4.80 Million | $-3.32 Million | 0.692x | -78.04% |
| 2013-12-31 | $-1.06 Million | $-3.33 Million | 3.154x | +232.47% |
| 2012-12-31 | $1.38 Million | $-3.28 Million | -2.381x | -230.59% |
| 2011-12-31 | $3.17 Million | $-2.28 Million | -0.720x | -547.07% |
| 2010-12-31 | $-57.22K | $-9.22K | 0.161x | -50.92% |
| 2009-12-31 | $-44.38K | $-14.56K | 0.328x | +224.67% |
| 2008-12-31 | $-29.08K | $-2.94K | 0.101x | -98.13% |
| 2007-12-31 | $-12.66K | $-68.53K | 5.414x | -- |